NRSN NeuroSense Therapeutics Ltd.
Healthcare$0.87+0.00%OpenMarket Cap: $21.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-13.35
P/S
0.00
EV/EBITDA
-3.14
DCF Value
$-0.03
FCF Yield
-0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
173600.0%
ROA
-633.3%
ROIC
465.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY null | $0.00 | NaN% | $-11.1M | $-11.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.3M | $-2.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.3M | $-2.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.8M | $-1.8M | $— | — |
| FY null | $0.00 | NaN% | $-9.9M | $-10.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.1M | $-2.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.0M | $-857.0K | $— | — |
| Q1 null | $0.00 | NaN% | $-3.0M | $-5.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.3M | $-3.0M | $— | — |
| FY null | $0.00 | NaN% | $-12.0M | $-10.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.9M | $784.0K | $— | — |
| Q2 2023 | $0.00 | NaN% | $-3.5M | $-5.2M | $-0.38 | — |